MedTrace Logo

Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women

NCT00440375 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2007-02-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of rosiglitazone on bone metabolism and to assess the association between the changes in bone turnover parameters and plasma cytokine levels in postmenopausal diabetic women

Conditions

Interventions

DRUG

Rosiglitazone

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Zehra Berberoglu · The Society of Endocrinology and Metabolism of Turkey

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30
Completion
2006-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00440375 on ClinicalTrials.gov